Back
Denali Therapeutics Stock Predictions
Sponsored
DNLI
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
68
DNLI
Denali Therapeutics
Last Price:
31.31
Seasonality Move:
6.34%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Denali Therapeutics Stock Forecast
- Over the next 52 weeks, Denali Therapeutics has on average historically risen by 28.4% based on the past 6 years of stock performance.
- Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Denali Therapeutics Stock Undervalued?
The current Denali Therapeutics [DNLI] share price is $31.35. The Score for DNLI is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - DNLI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Denali Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Denali Therapeutics has on average historically risen by 28.4% based on the past 6 years of stock performance.
Denali Therapeutics Stock Rating
Buy
68
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics overpriced?
- Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Denali Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com
52-Week Data
52-Week High:
32.13
52-Week Low:
14.56
Prediction Charts
Market Cap:
4.51B
Price in USD:
31.35
Volume:
713.08K
Beta:
1.57
Technical Analysis
SMA50:
27.75
SMA100:
25.34
SMA200:
22.07
52-Wk Change:
55.35%
Stock Predictions
-
Is Denali Therapeutics stock public?
Yes, Denali Therapeutics is a publicly traded company. -
What is the Denali Therapeutics stock quote today?
The Denali Therapeutics stock price is 31.35 USD today. -
How to buy Denali Therapeutics stock online?
You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-22 | 26.28 | 26.29 | 26.74 | 25.94 |
Oct-23 | 26.12 | 26.08 | 26.47 | 25.85 |
Oct-24 | 26.31 | 26.44 | 26.60 | 26.01 |
Oct-25 | 26.54 | 26.15 | 27.00 | 26.04 |
Oct-28 | 26.50 | 27.79 | 27.80 | 26.23 |
Oct-29 | 27.64 | 27.47 | 27.74 | 26.98 |
Oct-30 | 27.22 | 26.85 | 27.64 | 26.83 |
Oct-31 | 26.64 | 25.96 | 26.74 | 25.55 |
Nov-1 | 26.65 | 27.05 | 27.49 | 26.27 |
Nov-4 | 26.91 | 27.21 | 27.63 | 26.76 |
Nov-5 | 26.17 | 27.65 | 27.70 | 26.17 |
Nov-6 | 28.98 | 29.58 | 29.60 | 28.23 |
Nov-7 | 29.25 | 29.60 | 31.41 | 29.02 |
Nov-8 | 29.26 | 31.35 | 31.46 | 29.02 |
Denali Therapeutics Earnings
Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Denali Therapeutics Forecast Revenue Growth
Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.87 per share, and an increase next year of $0.05 per share.
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.